As we have reached the point in the Covid 19 pandemic, the vaccination program is essential to containing the pandemic.
The effectiveness and safety of our treatment services will increase—both of us who provide services in the field of health and those who receive services.
There is no evidence to show that the current vaccines cause infertility in both men and women.
It is recommended that all individuals that stay on and/or who are receiving treatment.
Vaccination knows that there is no evidence of adverse effects—vaccine administered in early pregnancy.
Before starting treatment with Assisted Reproductive Technologies (ART), minimize the complications that may develop due to the disease and complete the scheme by obtaining effective immunity during pregnancy.
Short-term fever, which may occur due to vaccination, may not significantly affect sperm parameters. While it is not expected to be affected in any way, the fever may negatively affect sperm parameters temporarily. Therefore, for our female patients and male patients, prevention of the disease and vaccination is essential.
Studies on patients receiving ART treatment show that pregnancy rates of individuals who have undergone, vaccinated and unvaccinated are similar.
As a result, the vaccine should be used in patients who benefit from ART.
There is no negative effect on treatment success.
The disease is more common in pregnant women than women in the same age group.
Hospitalization in intensive care and the need for more mechanical ventilation is known to cause many deaths. The risks include additional risks such as diabetes and obesity, which can increase in the presence of health problems. Therefore, for optimal protection, vaccination for women who conceive before completion is advised because they are at higher risk than individuals, and it is recommended that they complete their scheme. With the vaccine administered during pregnancy, similar immunity can be achieved with individuals without higher antibody levels than shown to be possible. In addition, as a result of vaccination, both cord blood antibodies have been reported in breast milk.
Studies on the vaccine’s safety in the United States have shown that mRNA vaccines do not affect pregnant women or babies.
Although not reported, any vaccine-related negativity in pregnancy outcomes in pregnant women, such as preterm labour due to the disease, is said to be safe and has no adverse effects.
In light of this data, we recommend that all our patients, both for their health and society’s health, contribute to their health and get vaccinated.
Society of Reproductive Medicine and Surgery
Board of Directors